Genetic Decryption of Leber Congenital Amaurosis (LCA) in a Large Cohort of Independent Families.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

659 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-09-30

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main objectives of this study are:

1. Improve genetic counseling by establishment of prevalences of each of genetic subtypes within a expanded population of patients with LCA taking into account ethnicity of families.
2. Confirm, refine or modify the genotype-phenotype correlations.
3. Edit important recommendations for:

* The clinical and paraclinical exploration of a new patient based on genotype, especially for extraocular explorations, to book at certain genetic subtypes
* Prenatal care of a couple.
* Directing families to a therapeutic protocol in progress or in development.
4. Individualize a panel of families without a mutation in the known genes and identify new genes responsible.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study characterize the clinical history of the disease (age and start mode of visual disturbances, rate and mode of progress of disease), careful assessment of retina function and finally, in search of the mutations responsible for this condition.

A full ophthalmic check-up, one at the inclusion and 24 months :

1. \- A genetic consultation taking account of family history and establishment of family tree with precision of geographical origin of birth of ascendants.
2. \- A thorough ophthalmologic examination by a referring medical ophthalmologist, including:

2.1 - An interrogation on the development of the visual awakening since the birth and its possible disturbances.

2.2 - The search for abnormal movements of the eyeballs, and difficulties with regard to different lighting.

2.3 - Visual field evaluation Survey.

2.4 - The study of color vision.

2.5 - The search for a refractive disorder with the automatic refractometer.

2.6 - Measurement of Visual acuity for near and distance.

2.7 - Examination of the eyeball as a whole, examination of the anterior chamber of the eye by the slit lamp.

2.8 - Taking pictures of the fundus of the eye after pupillary dilation.

2.9 - An autofluorescence search using a Scanning Laser Ophthalmoscopy (SLO).

2.10 - Optical Coherence Tomography (OCT) which used to assess the thickness of each of retinal layers.

2.11 - Electrophysiological examination, Electroretinogram (ERG) that allows to record the functional value of the retina.

These two latter examinations last on average 10 minutes after dilation of the pupil.
3. \- A blood sample of 10 milliliters to carry out genetic studies to identify the gene responsible for this condition and genetic counseling refined by taking account the results of this study.

Intermediate visit M12: only for patients younger than 6 years of age on inclusion.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Leber Congenital Amaurosis

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Leber Congenital Amaurosis Genetic Decryption The genotype-phenotype correlations Ethnicity families

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients:

* Patients of all ages
* Patients with symptoms the day of the first consultation allowing to ask the diagnosis of leber congenital amaurosis.
* Are affiliated to a social health care.
* Written informed consent must be given by patients or holders parental authority for minors.

patients and siblings:

* Signed consent for molecular study by the participant or by holders parental authority for minors.
* Are affiliated to a social health care.

Exclusion Criteria

* Patients whose exploration has laid differential diagnoses.
* Patients refusing the visits provided for in Protocol.

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Josseline KAPLAN, MD

Role: PRINCIPAL_INVESTIGATOR

Necker-Enfants Malades Hospital, 75015 Paris. France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Necker-Enfants Malades Hospital

Paris, Paris, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P081257

Identifier Type: -

Identifier Source: org_study_id